Sun Jia-jun, Li Chen, Wu Da-wei, Li Chen-hua, Qin Wei-hua, Li Ya-lin, Liu Qing-yue, Li Jin-xiu, Zou Yu-gang, Huang Dong-qinga, Xie Jian-jun, Li En-jie
Intensive Care Unit, the People's Second Hospital of Liaocheng, Linqing 252601, Shandong, China.
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2010 Mar;22(3):156-60.
To investigate the clinical feature, treatment and outcome of respiratory failure in patients with 2009 influenza A H1N1 infection in critically ill adults.
A prospective observational study of 18 patients with respiratory failure suffering from 2009 influenza A H1N1 infection admitted between November 22, 2009 and January 16, 2010. Their clinical data were analyzed.
Respiratory failure occurred in 18 patients with confirmed (n=9) or probable (n=9) 2009 influenza A H1N1. Among the 18 patients 8 patients were male, 10 patients were female (7 were pregnant or postpartum). Eight patients had pre-existing medical conditions. Twelve patients were between 20 and 40 years of age, the mean age was 37.1 years. Three were obese with body mass index over 30 kg/m (2). The 28-day mortality was 33.3% (6/18) with 1 additional late death. The median duration from the onset of the illness to hospital admission was 4.1 days (1-5 days) and from the onset to first dose of oseltamivir was 5.5 days (2-12 days), from onset to mechanical ventilation initiation was 6.8 days (4-12 days). Seventeen patients had primary viral pneumonia and 1 patient had an asthma exacerbation and 3 patients experienced multiple organ dysfunction syndrome (MODS). Twelve patients received corticosteroids, 10 patients required vasopressors. All patients were mechanically ventilated, 1 patient underwent extracorporeal membrane oxygenation (ECMO). Patients who died had higher acute physiology and chronic health evaluation II score compared to survivors (29.2 + or - 7.3 vs. 18.6 + or - 6.4, P=0.02). All deceased patients received high-level ventilation settings [peak inspiratory pressure > or = 35 cm H(2)O (1 cm H(2)O=0.098 kPa) and positive end-expiratory pressure > or = 18 cm H(2)O] within the first 7 days of ventilation, and the hypoxemia [oxygenation index < or = 60 mm Hg (1 mm Hg=0.133 kPa)] lasted 24 hours. In contrast only 1 among survivors did (9.1% vs. 100.0%, P<0.01). Compared with survivors, acute kidney injury and barotrauma occurred more frequently in non-survivors (42.9% vs. 27.3%, 28.6% vs. 9.1%, both P<0.05). Whereas all deceased patients received vasopressors, only 4 survivors required vasopressor support (100.0% vs. 36.4%, P<0.05).
Severe acute respiratory distress syndrome is the most common manifestation in critically ill patients with 2009 influenza A H1N1 infection in adult. Failure to obtain satisfactory oxygenation with high-level ventilation settings within the first 7-days, onset of acute kidney injury and barotrauma, and continuous need for vasopressors portend a poor prognosis.
探讨2009年甲型H1N1流感感染的危重症成年患者呼吸衰竭的临床特征、治疗方法及预后。
对2009年11月22日至2010年1月16日收治的18例2009年甲型H1N1流感感染所致呼吸衰竭患者进行前瞻性观察研究,并分析其临床资料。
18例确诊(n = 9)或疑似(n = 9)2009年甲型H1N1流感感染患者发生呼吸衰竭。18例患者中,男性8例,女性10例(7例为孕妇或产后女性)。8例患者有基础疾病。12例患者年龄在20至40岁之间,平均年龄为37.1岁。3例肥胖,体重指数超过30kg/m²。28天死亡率为33.3%(6/18),另有1例晚期死亡。从发病到入院的中位时间为4.1天(1 - 5天),从发病到首次服用奥司他韦的时间为5.5天(2 - 12天),从发病到开始机械通气的时间为6.8天(4 - 12天)。17例患者为原发性病毒性肺炎,1例患者为哮喘加重,3例患者发生多器官功能障碍综合征(MODS)。12例患者接受了皮质类固醇治疗,10例患者需要血管活性药物支持。所有患者均接受机械通气,1例患者接受了体外膜肺氧合(ECMO)治疗。与幸存者相比,死亡患者的急性生理与慢性健康状况评分II(APACHE II)更高(29.2±7.3 vs. 18.6±6.4,P = 0.02)。所有死亡患者在通气的前7天内均接受了高通气设置[吸气峰压≥35cmH₂O(1cmH₂O = 0.098kPa)且呼气末正压≥18cmH₂O],且低氧血症[氧合指数≤60mmHg(1mmHg = 0.133kPa)]持续24小时。相比之下,幸存者中只有1例如此(9.1% vs. 100.0%,P < 0.01)。与幸存者相比,非幸存者急性肾损伤和气压伤的发生率更高(42.9% vs. 27.3%,28.6% vs. 9.1%,P均<0.05)。所有死亡患者均接受血管活性药物支持,而只有4例幸存者需要血管活性药物支持(100.0% vs. 36.4%,P < 0.05)。
严重急性呼吸窘迫综合征是2009年甲型H1N1流感感染的危重症成年患者最常见的表现。通气前7天内未能通过高通气设置获得满意的氧合、急性肾损伤和气压伤的发生以及持续需要血管活性药物支持预示着预后不良。